Skip to content

Study on the efficacy of topical semi-solid Rosa damascena product in treatment of chronic hand eczema

Study on the efficacy of topical semi-solid Rosa damascena product in treatment of chronic hand eczema in comparison with placebo

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150825023753N18
Enrollment
42
Registered
2020-12-06
Start date
2020-09-22
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hand Eczema. (chronic) eczema

Interventions

Intervention 1: Intervention group: Dosage for each hand is 0.5 g, which is explained to the patient in the form of a phalanx unit (from the skin fold of the tip of the adult finger to the tip of the

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: A patient aged 18 to 65 years with a diagnosis of chronic eczema by a dermatologist The patient's cooperation to eliminate or reduce environmental irritants and is bound to cooperate for regular use of the studied drug and referral enters the research project at the appointed time after signing the informed consent form. The patient agrees to participate in the study

Exclusion criteria

Exclusion criteria: Patient dissatisfaction with participation in the study Severe or refractory eczema that requires oral or topical steroids. Use topical medications during 2 weeks before starting the research project Use of systemic immunosuppressive drugs during one month before starting the research project Having obsessive-compulsive disorder for frequent hand washing Patients suspected of having concomitant fungal diseases

Design outcomes

Primary

MeasureTime frame
The rate of improvement of itching. Timepoint: Measurements are taken at the start of the study and one month after the start of the study. Method of measurement: To evaluate the patient, two criteria of HECSI index (hand eczema severity index) and Visual Analog Scale are used.;Scaling recovery rate. Timepoint: Measurements are taken at the start of the study and one month after the start of the study. Method of measurement: To evaluate the patient, two criteria of HECSI index (hand eczema severity index) and Visual Analog Scale are used.;Healing hand blisters. Timepoint: Measurements are taken at the start of the study and one month after the start of the study. Method of measurement: To evaluate the patient, two criteria of HECSI index (hand eczema severity index) and Visual Analog Scale are used.;The rate of recovery of hand cracks. Timepoint: Measurements are taken at the start of the study and one month after the start of the study. Method of measurement: To evaluate the patient, two criteria of HECSI index (hand eczema severity index) and Visual Analog Scale are used.;Reducing redness of the skin of the hands. Timepoint: Measurements are taken at the start of the study and one month after the start of the study. Method of measurement: To evaluate the patient, two criteria of HECSI index (hand eczema severity index) and Visual Analog Scale are used.;Extent of skin involvement of patients. Timepoint: Measurements are taken at the start of the study and one month after the start of the study. Method of measurement: The Visual Analog Scale criterion is used to evaluate the patient.;Healing swelling. Timepoint: Measurements are taken at the start of the study and one month after the start of the study. Method of measurement: To evaluate the patient, two criteria of HECSI index (hand eczema severity index) and Visual Analog Scale are used.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Mohammad Mahdi Parvizi

Shiraz University of Medical Sciences

mmparvizi@gmail.com+98 71 3212 5592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026